Real-world monitoring of asthma control with a combination inhaler

This is a 6-month safety and effectiveness study of Enerzair, a combination asthma inhaler that delivers three medications in one dose. Adult patients with asthma who are already being prescribed this medication by their doctor will be asked to participate in routine monitoring. The study simply observes how the medication works in everyday life—no extra tests or visits are required beyond standard asthma care.

Health authorities in Korea require companies to monitor how new medications perform once they're being used by real patients outside of strict clinical trial settings. This study helps ensure the medication continues to be safe and effective when prescribed in regular medical practice.